Vaccine with syringe

Cell & Gene Therapy

Developing and launching a successful cell and gene therapy requires specialist expertise and out-of-the-box thinking to adapt to new business models and pricing strategies. CRA has significant experience in this space and understands the unique challenges that gene or cell therapies can bring to manufacturers and the healthcare industry. We bring industry-leading methodologies from clinical development through launch to support commercial, medical affairs, pricing, market access, and policy makers/regulators in navigating a rapidly evolving landscape.

Our offerings

We are gene therapy specialists.

CRA’s experience stems from more than 100 gene therapy engagements across multiple therapeutic areas.

  • 50+
    Gene therapy engagements since 2022
  • 20+
    Disease areas covered


  • 01
    Business development search to assess the commercial attractiveness of the gene therapy pipeline
    Our client sought to assess a broad range of indications in which gene therapy is being developed and create a comprehensive map of the landscape to facilitate...
    View engagement
  • 02
    Commercial assessment of early-stage gene editing technology for sickle cell disease and β-thalassemia
    Our client asked us to identify and prioritize opportunities for a technologically novel approach to gene editing for two indications in which it may be a late...
    View engagement
  • 03
    Development of GTx site-readiness playbook for an investigational product
    CRA’s client, a multinational healthcare company, aimed to develop a site-readiness playbook to support launch planning for an investigational gene transfer...
    View engagement

Contact a Cell & Gene Therapy expert.

See all Cell & Gene Therapy experts

Subscribe to receive our latest Insights.